Lead Sponsor

Kaiser Permanente

Collaborators

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•Adults ≥18 years.
•Underwent routine TTE within site defined recent timeframe and flagged as high risk for MASLD and/or cirrhosis by the AI model using pre specified threshold.
•Able to provide informed consent; reachable for follow up.

•Inability to consent or communicate.
•Enrollment in hospice or life expectancy so limited that additional evaluation would not be appropriate per clinician judgment.
•Clinical circumstances where immediate alternative diagnostic pathways supersede study procedures (e.g., acute decompensation requiring urgent management).
•Prior liver or kidney transplant.
•Patient unwilling to undergo prospective testing for liver disease.

Related studies

NCT06345547 · Sarcopenia, Cirrhosis, and more

NCT07069725 · Liver Fibrosis, Hepatic Cirrhosis

NCT07439939 · Liver Cirrhosis, Portal Hypertension

NCT05623150 · Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, and more

NCT05899231 · Cirrhosis, Liver, Liver Transplant Surgery, and more

Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)